MIRA Pharma Stock Skyrockets 100% Overnight as New Pain Drug Outshines Morphine
MIRA Pharmaceuticals’ stock price skyrocketed overnight on the back of surprising good news. The relatively obscure biotech – which trades on the Nasdaq Capital Market under ticker MIRA – closed Wednesday, Oct. 15 at $1.32 per sharebenzinga.com. That modest close gave little hint of what was to come. After the market shut, MIRA stunned investors with a press release detailing remarkable lab results for its lead drug candidate. The reaction was immediate: shares surged 68.94% in after-hours trading, reaching $2.23benzinga.com. And the rally didn’t stop there. By Thursday morning in pre-market dealings, MIRA’s stock was trading as high as $2.74 – more than double its prior day’s closemarketbeat.com. Such a steep jump is highly unusual, turning heads in the investment community. Volume spiked as well – nearly 3.7 million shares changed hands on Wednesdayinkl.com, and heavy trading likely continued into Thursday’s pre-market. For context, MIRA’s 52-week trading range had been roughly $0.73 to $2.56 before this newsinkl.com. That means the stock is now challenging its annual high. Even after the pop, MIRA remains a micro-cap company. Such micro-cap biotech stocks are prone to volatility – but a one-day doubling stands out even in this volatile sector.
